» Articles » PMID: 38953049

Heavy Menstrual Bleeding on Direct Factor Xa Inhibitors: the MEDEA Randomized Clinical Trial

Citing Articles

Safe and effective anticoagulation use: case studies in anticoagulation stewardship.

May J, Allen A, Samuelson Bannow B, OConnor C, Sylvester K, Kaatz S J Thromb Haemost. 2024; 23(3):779-789.

PMID: 39667688 PMC: 11890946. DOI: 10.1016/j.jtha.2024.11.024.


Déjà vu all over again: a recurrent flaw in anticoagulant study design.

Samuelson Bannow B, Edelman A, Carrier M J Thromb Haemost. 2024; 23(1):23-26.

PMID: 39476970 PMC: 11725431. DOI: 10.1016/j.jtha.2024.10.019.


Starving in the land of plenty: the challenge of studying menstruation in anticoagulated patients.

Samuelson Bannow B Res Pract Thromb Haemost. 2024; 8(4):102500.

PMID: 39091720 PMC: 11293560. DOI: 10.1016/j.rpth.2024.102500.

References
1.
Patel J, Nzelu O, Roberts L, Johns J, Ross J, Arya R . How do anticoagulants impact menstrual bleeding and quality of life? - The PERIOD study. Res Pract Thromb Haemost. 2023; 7(2):100072. PMC: 9969064. DOI: 10.1016/j.rpth.2023.100072. View

2.
Boonyawat K, OBrien S, Bates S . How I treat heavy menstrual bleeding associated with anticoagulants. Blood. 2017; 130(24):2603-2609. DOI: 10.1182/blood-2017-07-797423. View

3.
Fraser I, Critchley H, Broder M, Munro M . The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med. 2011; 29(5):383-90. DOI: 10.1055/s-0031-1287662. View

4.
Cooper N, Rivas C, Munro M, Critchley H, Clark T, Matteson K . Standardising outcome reporting for clinical trials of interventions for heavy menstrual bleeding: Development of a core outcome set. BJOG. 2023; 130(11):1337-1345. DOI: 10.1111/1471-0528.17473. View

5.
Bistervels I, Scheres L, Hamulyak E, Middeldorp S . Sex matters: Practice 5P's when treating young women with venous thromboembolism. J Thromb Haemost. 2019; 17(9):1417-1429. PMC: 6852403. DOI: 10.1111/jth.14549. View